Vispearl® Radiopaque Drug-Eluting Embolic Microspheres: Nationwide Multicenter Clinical Trial Launched at CIC 2024 with Academic Leadership from Academician Teng Gaojun

The 18th Annual Conference of Interventional Therapy (CIC2024) and the 3rd Annual Conference of the Liaoning Provincial Society for Life Sciences on Interventional Medicine, the 4th "Bone Strength" Interventional Therapy Conference, and the 3rd Academic Conference on Interventional Nursing of the Liaoning Nursing Association will be grandly held at Shenyang New World Hotel from August 23 to 25, 2024.

This session features topics on tumors, blood vessels, nerves, non-vascular and interventional care, andCombining the discussion of difficult cases and expert keynote speeches, interventional practitioners can fully understand advanced equipment and devices both in China and internationally, as well as new technologies and methods in interventional diagnosis and treatment, improving the diagnostic and treatment skills of interventional physicians and standardizing surgical procedures.HuiHe Healthcare will unveil its newly launched Vispearl^®The visible drug-loaded embolic microspheres participated in this grand event, and we sincerely look forward to the presence of experts at the booth for guidance and exchange.

At the same time, to further explore the improvement and popularization of visibility and ultra-small particle size in interventional treatment concepts and refined TACE, Academician Gaojun Teng from Zhongda Hospital Affiliated to Southeast University and Professor Zhiping Yan from Zhongshan Hospital Affiliated to Fudan University have joined hands with HuiHe Healthcare to jointly initiate the first full-size visible drug-loaded embolic microspheres in China.Multi-center Clinical Trial. HuiHe Healthcare willAugust 24, inOne Polymerization Sub-venueHost "Vispearl® Radiopaque Drug-Eluting Embolic Microspheres Multi-Center Clinical Trial Investigator Meeting in China"，We sincerely invite you to attend!"